Structural basis of receptor usage by the engineered capsid AAV-PHP.eB

Adeno-associated virus serotype 9 (AAV9) is a promising gene therapy vector for treating neurodegenerative diseases due to its ability to penetrate the blood-brain barrier. PHP.eB was engineered from AAV9 by insertion of a 7-amino acid peptide and point mutation of neighboring residues, thereby enha...

Full description

Bibliographic Details
Main Authors: Seongmin Jang, Hao K. Shen, Xiaozhe Ding, Timothy F. Miles, Viviana Gradinaru
Format: Article
Language:English
Published: Elsevier 2022-09-01
Series:Molecular Therapy: Methods & Clinical Development
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2329050122001036
_version_ 1811216795581808640
author Seongmin Jang
Hao K. Shen
Xiaozhe Ding
Timothy F. Miles
Viviana Gradinaru
author_facet Seongmin Jang
Hao K. Shen
Xiaozhe Ding
Timothy F. Miles
Viviana Gradinaru
author_sort Seongmin Jang
collection DOAJ
description Adeno-associated virus serotype 9 (AAV9) is a promising gene therapy vector for treating neurodegenerative diseases due to its ability to penetrate the blood-brain barrier. PHP.eB was engineered from AAV9 by insertion of a 7-amino acid peptide and point mutation of neighboring residues, thereby enhancing potency in the central nervous system. Here, we report a 2.24-Å resolution cryo-electron microscopy structure of PHP.eB, revealing conformational differences from other 7-mer insertion capsid variants. In PHP.eB, the 7-mer loop adopts a bent conformation, mediated by an interaction between engineered lysine and aspartate residues. Further, we identify PKD2 as the main AAV receptor (AAVR) domain recognizing both AAV9 and PHP.eB and find that the PHP.eB 7-mer partially destabilizes this interaction. Analysis of previously reported AAV structures together with our pull-down data demonstrate that the 7-mer topology determined by the lysine-aspartate interaction dictates AAVR binding strength. Our results suggest that PHP.eB’s altered tropism may arise from both an additional interaction with LY6A and weakening of its AAVR interaction. Changing the insertion length, but not sequence, modifies PKD2 binding affinity, suggesting that a steric clash impedes AAVR binding. This research suggests improved library designs for future AAV selections to identify non-LY6A-dependent vectors and modulate AAVR interaction strength.
first_indexed 2024-04-12T06:45:17Z
format Article
id doaj.art-df4fd9859c1b4dfeae3dfa8b780af72e
institution Directory Open Access Journal
issn 2329-0501
language English
last_indexed 2024-04-12T06:45:17Z
publishDate 2022-09-01
publisher Elsevier
record_format Article
series Molecular Therapy: Methods & Clinical Development
spelling doaj.art-df4fd9859c1b4dfeae3dfa8b780af72e2022-12-22T03:43:37ZengElsevierMolecular Therapy: Methods & Clinical Development2329-05012022-09-0126343354Structural basis of receptor usage by the engineered capsid AAV-PHP.eBSeongmin Jang0Hao K. Shen1Xiaozhe Ding2Timothy F. Miles3Viviana Gradinaru4Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USADivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 91125, USADivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USADivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USADivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA; Corresponding author Viviana Gradinaru, PhD, Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA.Adeno-associated virus serotype 9 (AAV9) is a promising gene therapy vector for treating neurodegenerative diseases due to its ability to penetrate the blood-brain barrier. PHP.eB was engineered from AAV9 by insertion of a 7-amino acid peptide and point mutation of neighboring residues, thereby enhancing potency in the central nervous system. Here, we report a 2.24-Å resolution cryo-electron microscopy structure of PHP.eB, revealing conformational differences from other 7-mer insertion capsid variants. In PHP.eB, the 7-mer loop adopts a bent conformation, mediated by an interaction between engineered lysine and aspartate residues. Further, we identify PKD2 as the main AAV receptor (AAVR) domain recognizing both AAV9 and PHP.eB and find that the PHP.eB 7-mer partially destabilizes this interaction. Analysis of previously reported AAV structures together with our pull-down data demonstrate that the 7-mer topology determined by the lysine-aspartate interaction dictates AAVR binding strength. Our results suggest that PHP.eB’s altered tropism may arise from both an additional interaction with LY6A and weakening of its AAVR interaction. Changing the insertion length, but not sequence, modifies PKD2 binding affinity, suggesting that a steric clash impedes AAVR binding. This research suggests improved library designs for future AAV selections to identify non-LY6A-dependent vectors and modulate AAVR interaction strength.http://www.sciencedirect.com/science/article/pii/S2329050122001036adeno-associated virusAAVAAVRLY6APHP.eBblood-brain barrier
spellingShingle Seongmin Jang
Hao K. Shen
Xiaozhe Ding
Timothy F. Miles
Viviana Gradinaru
Structural basis of receptor usage by the engineered capsid AAV-PHP.eB
Molecular Therapy: Methods & Clinical Development
adeno-associated virus
AAV
AAVR
LY6A
PHP.eB
blood-brain barrier
title Structural basis of receptor usage by the engineered capsid AAV-PHP.eB
title_full Structural basis of receptor usage by the engineered capsid AAV-PHP.eB
title_fullStr Structural basis of receptor usage by the engineered capsid AAV-PHP.eB
title_full_unstemmed Structural basis of receptor usage by the engineered capsid AAV-PHP.eB
title_short Structural basis of receptor usage by the engineered capsid AAV-PHP.eB
title_sort structural basis of receptor usage by the engineered capsid aav php eb
topic adeno-associated virus
AAV
AAVR
LY6A
PHP.eB
blood-brain barrier
url http://www.sciencedirect.com/science/article/pii/S2329050122001036
work_keys_str_mv AT seongminjang structuralbasisofreceptorusagebytheengineeredcapsidaavphpeb
AT haokshen structuralbasisofreceptorusagebytheengineeredcapsidaavphpeb
AT xiaozheding structuralbasisofreceptorusagebytheengineeredcapsidaavphpeb
AT timothyfmiles structuralbasisofreceptorusagebytheengineeredcapsidaavphpeb
AT vivianagradinaru structuralbasisofreceptorusagebytheengineeredcapsidaavphpeb